Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study. (Q47994270)

7 February 2018

title

Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study. (English)

1 reference

7 February 2018

7

Kuninori Shiwaku

1 reference

7 February 2018

author name string

Tao Wang

1

1 reference

7 February 2018

Kenji Karino

2

1 reference

7 February 2018

Masayuki Yamasaki

3

1 reference

7 February 2018

Yan Zhang

4

1 reference

7 February 2018

Junichi Masuda

5

1 reference

7 February 2018

Shuhei Yamaguchi

6

1 reference

7 February 2018

Toru Nabika

8

1 reference

7 February 2018

publication date

16 April 2009

1 reference

7 February 2018

Journal of Clinical Hypertension

published in

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

742-747

1 reference

7 February 2018

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study).

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Oxidized phospholipids as a new landmark in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

The role of oxidized lipoproteins in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Oxidative stress and cardiovascular injury: Part II: animal and human studies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Innate and acquired immunity in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Relation of markers of inflammation (C-reactive protein, white blood cell count, and lipoprotein-associated phospholipase A2) to the ankle-brachial index.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

What cause of mortality can we predict by cholesterol screening in the Japanese general population?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2009.70

7 January 2021

Identifiers

DOI

10.1038/AJH.2009.70

1 reference

7 February 2018

release_cyikxxqqhzdy7mad5d42y2v7jq

Fatcat ID

0 references

PubMed ID

19373214

1 reference

7 February 2018